FDA Gets Two Death Reports Tied to Black Market Retatrutide

The FDA has received at least two reports of deaths linked to illicit retatrutide, an unapproved Eli Lilly weight loss drug, according to documents obtained by CBS News. The patients, aged 41 and 49, reportedly took the drug from unreliable sources.

• FDA received two death reports tied to black market retatrutide in 2026
• Eli Lilly's retatrutide mimics GLP-1, GIP and glucagon, cutting weight up to 30%
• The drug is unapproved anywhere but is already sold online
• Australia reported a patient who tore their esophagus from constant vomiting